Paul N. Maton

Medicine · Health Sciences

49h-index7.8kcitations146works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Neuroendocrine Tumor Research Advances(68), Neuroblastoma Research and Treatments(26), PI3K/AKT/mTOR signaling in cancer(24), Neuropeptides and Animal Physiology(22), Gastroesophageal reflux and treatments(20)

Publications146 total

Conception et déploiement d’un réseau d’IoT en technologie LoRa permettant de connecter l’ENSEIRB-MATMECA
HAL (Le Centre pour la Communication Scientifique Directe)·2017
Healing Marginal Ulcers in Patients Who Have Had a Roux-en-Y Gastric Bypass
Clinical Gastroenterology and Hepatology·2017· 1 cited
Review article: prevention of stress‐related mucosal bleeding with proton‐pump inhibitors
Alimentary Pharmacology & Therapeutics·2005· 16 cited
Gastrinoma
Encyclopedia of Gastroenterology·2004· 1 cited
Gastrinoma
Encyclopedia of Gastroenterology·2004
Zollinger-Ellison Syndrome and Other Acid-Hypersecretory States
Humana Press eBooks·2003
The impact of baseline severity of erosive esophagitis (EE) on heartburn (HB) resolution in patients treated with esomeprazole or omeprazole
Gastroenterology·2001· 2 cited
Efficacy and safety of esomeprazole compared with omeprazole in GERD patients with erosive esophagitis: a randomized controlled trial
The American Journal of Gastroenterology·2001· 394 cited
Efficacy and safety of esomeprazole compared with omeprazole in GERD patients with erosive esophagitis: a randomized controlled trial.
PubMed·2001· 127 cited
Safety and Efficacy of Long Term Esomeprazole Therapy in Patients with Healed Erosive Oesophagitis
Drug Safety·2001· 35 cited
Zollinger-Ellison Syndrome and Other Acid-Hypersecretory States
Humana Press eBooks·2001Open Access
Salivary and Gastric Epidermal Growth Factor in Patients With Zollinger-Ellison Syndrome: Its Protective Potential
The American Journal of Gastroenterology·2000· 22 cited
Safety and efficacy of long-term treatment with esomeprazole in patients with healed erosive esophagitis (EE)
Gastroenterology·2000· 5 cited
Oral and intravenous dosage forms of pantoprazole are equivalent in their ability to suppress gastric acid secretion in patients with gastroesophageal reflux disease
The American Journal of Gastroenterology·2000· 55 cited
Efficacy of omeprazole versus ranitidine for symptomatic treatment of poorly responsive acid reflux disease—a prospective, controlled trial
Alimentary Pharmacology & Therapeutics·1999· 22 citedOpen Access
Limp as unusual presentation of Langerhans' cell histiocytosis
European Journal of Pediatrics·1999· 8 cited
Antacids Revisited
Drugs·1999· 161 cited
The ability of operative endoscopic transillumina- Detection of Duodenal Gastrinomas by
1999
Meal type affects heartburn severity
European Journal of Gastroenterology & Hepatology·1998
The Impact of Gastroesophageal Reflux Disease on Health-related Quality of Life
The American Journal of Medicine·1998· 429 cited
page 1 of 8Next →

Frequent Co-authors

Robert T. Jensen(23), Jerry D. Gardner(21), John L. Doppman(12), Jeffrey A. Norton(10), Rakesh Vinayek(9), Harold Frucht(7), Martin J. Collen(6), V. S. Chadwick(5), S.A. Wank(5), John M. Howard(4), R. H. Dowling(3), K.E. McArthur(3), Jay A. Cherner(3), M.J. Cornelius(3), R. T. Jensen(3), Debra L. Miller(3), James I. Slaff(3), J A Norton(3), David C. Metz(3), Clare Selden(3)